SCHEMBL7747328

SCHEMBL7747328

O=[C]CN(NC(=O)c1ccco1)C(=O)C=Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.51
L3MBTL1 Q9Y468 5/20 0.51
KDM4E B2RXH2 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 7/20 0.45
ALDH1A1 P00352 3/20 0.45
POLB P06746 2/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
RAB9A P51151 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 1/20 0.43
TNIK Q9UKE5 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
GAA P10253 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7747325 1.00 MAPT (0.51) MAPTL3MBTL1KDM4ETDP1MAPK1
SCHEMBL7750101 0.83 NPC1 (0.46) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7750096 0.83 NPC1 (0.46) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7746686 0.81 HDAC3 (0.41) MAPTL3MBTL1KDM4ETDP1NPC1
SCHEMBL7746688 0.81 HDAC3 (0.41) MAPTL3MBTL1KDM4ETDP1NPC1
SCHEMBL7749846 0.79 NPC1 (0.50) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7747853 0.79 NPC1 (0.47) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7749839 0.79 NPC1 (0.50) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7747851 0.79 NPC1 (0.47) MAPTL3MBTL1TDP1NPC1ALDH1A1
SCHEMBL7746501 0.78 NPC1 (0.46) MAPTL3MBTL1TDP1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
US-5750699-A HALOGENATING OF CORRESPONDING COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed
US-5574042-A ANTAGONIST FOR BRADYKININS AS ANTIALLERGENS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, SHOCK OR PAIN FUJISAWA PHARMACEUTICAL CO., LTD (JP) 1996-11-12 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed